| |
|
|
|
Oncosec Medical  
|
|
1.56 0.04 (0.03%) |
05-22 16:00 |
|
Open: |
1.55 |
Pre close: |
1.52 |
Target:
|
1.95
|
|
High: |
1.59 |
Low: |
1.529 |
Resistance:
|
1.67
1.80
|
|
Volume: |
418,164 |
Market Cap: |
80M |
Support:
|
1.45
1.21
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.62
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.57  |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
1.79 |
Stochastic Oscillator |
%K(14,3):
|
29.80 |
|
MA(250): |
1.47 |
%D(3): |
44.22 |
|
Average Volume(K) |
3-Month: |
122588
|
52-Week |
High:
|
2.95 |
|
10-Days: |
101772 |
Low: |
0.88 |
|
RSI |
RSI(14):
|
45.83 |
Change(%): |
56.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.060 |
Return on Equity (ttm) |
-143.6 |
Shares Out. (M) |
51.48 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-116.7 |
Shares Float (M) |
49.78 |
|
EPS Est. Next Year |
-0.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.30 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
15.60 |
|
Forward EPS |
-0.670 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5041 |
|
Book Value (p.s.) |
4.510 |
EBITDA (p.s.) |
-0.416 |
P/E |
-1.47 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.35 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-20.32 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.49 |
P/CF |
-3.95 |
|
|
|
|
|
|
